# Mass General Brigham Ventures

Mass General Brigham Ventures is a Venture Capital based in Somerville, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Somerville, United States
- **Region:** Europe
- **Address:** Cambridge, MA, United States
- **Founded:** 2008
- **Assets under management:** Undisclosed
- **Website:** massgeneralbrighamventures.com
- **LinkedIn:** https://www.linkedin.com/company/mass-general-brigham-ventures

## Regulatory record

- **CRD number:** 286361
- **SEC file number:** 802-108906
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/286361

## About

Mass General Brigham Ventures is an exempt reporting adviser in Somerville, MA, established in 2016. It has been registered since then.

## Sectors

- Digital Health
- Enterprise Software
- AI/ML
- Healthcare Services
- Robotics & Automation

## Questions

### How does Mass General Brigham Ventures source its investments?

The fund holds a proprietary right to review all commercially viable innovations emerging from the Mass General Brigham system, which includes 16 member institutions and over $2 billion in annual NIH-funded research. This provides a structured pipeline unmatched by independent VCs. Deals are sourced through direct relationships with principal investigators, clinician-entrepreneurs, and the technology transfer offices of Harvard Medical School-affiliated hospitals.

### Does the fund invest outside of Mass General Brigham-affiliated companies?

Yes, on a selective basis. While the primary pipeline draws from the parent system's research enterprise, the fund has co-invested alongside top-tier healthcare VCs in opportunities originating from other academic medical centers. Its syndication relationships with external venture firms create visibility into non-affiliated deal flow, though the majority of portfolio activity remains tied to the Mass General Brigham innovation ecosystem.

### Which therapeutic areas does the fund focus on?

Therapeutics, medical devices, diagnostics, and digital health constitute the core investment verticals, reflecting the clinical strengths of the Mass General Brigham system. Within these verticals, the fund has backed companies in oncology, neurology, cardiology, and infectious disease. The parent system's clinical data assets and patient populations provide validating real-world evidence that underpins many portfolio company value propositions.

### How does the fund handle conflicts of interest given its links to the hospital system?

Mass General Brigham Ventures operates under a formal conflict-of-interest policy that governs interactions between the investment team, the system's technology transfer offices, and clinician-inventors. Portfolio companies are structured independently, and investment decisions are made by the venture team without interference from the clinical or administrative leadership of the hospitals. This firewall is designed to prevent institutional influence from distorting investment outcomes.

## Related profiles

- [ATL Partners](https://altss.com/profile/atl-partners)
- [AMCI Group](https://altss.com/profile/amci-group)

---

Last updated: 2026-08-14T12:30:00.000Z

Canonical page: https://altss.com/profile/mass-general-brigham-ventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology